Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
TENET HEALTHCARE CORP reported the quarter ended December 31, 2023 results: revenue $5,379, net income $244 million, EPS $2.30 per diluted share. Guidance raised.
- Period
- the quarter ended December 31, 2023
- Revenue
- $5,379
- Net income
- $244 million
- EPS
- $2.30 per diluted share
- Guidance
- raised
- Result
- reported results
Exact text from the filing
2022 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
TENET HEALTHCARE CORP reported the year ended December 31, 2023 results: revenue $20,548, net income $611 million, EPS $5.71 per diluted share. Guidance raised.
- Period
- the year ended December 31, 2023
- Revenue
- $20,548
- Net income
- $611 million
- EPS
- $5.71 per diluted share
- Guidance
- raised
- Result
- reported results
Exact text from the filing
as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from continuing
View on SEC.gov